Cargando…
Distinct immunologic changes in vivo following combination versus individual PD-1 or CTLA-4 checkpoint blockade in human cancer
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288370/ http://dx.doi.org/10.1186/2051-1426-2-S3-O7 |
| _version_ | 1782351957552267264 |
|---|---|
| author | Dhodapkar, Kavita Verma, Rakesh Sznol, Mario Boddupalli, Chandra Sekhar Gettinger, Scott Kluger, Harriet Dhodapkar, Madhav Das, Rituparna |
| author_facet | Dhodapkar, Kavita Verma, Rakesh Sznol, Mario Boddupalli, Chandra Sekhar Gettinger, Scott Kluger, Harriet Dhodapkar, Madhav Das, Rituparna |
| author_sort | Dhodapkar, Kavita |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4288370 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2014 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-42883702015-01-15 Distinct immunologic changes in vivo following combination versus individual PD-1 or CTLA-4 checkpoint blockade in human cancer Dhodapkar, Kavita Verma, Rakesh Sznol, Mario Boddupalli, Chandra Sekhar Gettinger, Scott Kluger, Harriet Dhodapkar, Madhav Das, Rituparna J Immunother Cancer Oral Presentation BioMed Central 2014-11-06 /pmc/articles/PMC4288370/ http://dx.doi.org/10.1186/2051-1426-2-S3-O7 Text en Copyright © 2014 Dhodapkar et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Oral Presentation Dhodapkar, Kavita Verma, Rakesh Sznol, Mario Boddupalli, Chandra Sekhar Gettinger, Scott Kluger, Harriet Dhodapkar, Madhav Das, Rituparna Distinct immunologic changes in vivo following combination versus individual PD-1 or CTLA-4 checkpoint blockade in human cancer |
| title | Distinct immunologic changes in vivo following combination versus individual PD-1 or CTLA-4 checkpoint blockade in human cancer |
| title_full | Distinct immunologic changes in vivo following combination versus individual PD-1 or CTLA-4 checkpoint blockade in human cancer |
| title_fullStr | Distinct immunologic changes in vivo following combination versus individual PD-1 or CTLA-4 checkpoint blockade in human cancer |
| title_full_unstemmed | Distinct immunologic changes in vivo following combination versus individual PD-1 or CTLA-4 checkpoint blockade in human cancer |
| title_short | Distinct immunologic changes in vivo following combination versus individual PD-1 or CTLA-4 checkpoint blockade in human cancer |
| title_sort | distinct immunologic changes in vivo following combination versus individual pd-1 or ctla-4 checkpoint blockade in human cancer |
| topic | Oral Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288370/ http://dx.doi.org/10.1186/2051-1426-2-S3-O7 |
| work_keys_str_mv | AT dhodapkarkavita distinctimmunologicchangesinvivofollowingcombinationversusindividualpd1orctla4checkpointblockadeinhumancancer AT vermarakesh distinctimmunologicchangesinvivofollowingcombinationversusindividualpd1orctla4checkpointblockadeinhumancancer AT sznolmario distinctimmunologicchangesinvivofollowingcombinationversusindividualpd1orctla4checkpointblockadeinhumancancer AT boddupallichandrasekhar distinctimmunologicchangesinvivofollowingcombinationversusindividualpd1orctla4checkpointblockadeinhumancancer AT gettingerscott distinctimmunologicchangesinvivofollowingcombinationversusindividualpd1orctla4checkpointblockadeinhumancancer AT klugerharriet distinctimmunologicchangesinvivofollowingcombinationversusindividualpd1orctla4checkpointblockadeinhumancancer AT dhodapkarmadhav distinctimmunologicchangesinvivofollowingcombinationversusindividualpd1orctla4checkpointblockadeinhumancancer AT dasrituparna distinctimmunologicchangesinvivofollowingcombinationversusindividualpd1orctla4checkpointblockadeinhumancancer |